|
ABL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.129600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.912000E-01 |
| Normal-vs-Stage2 |
2.114400E-01 |
| Normal-vs-Stage3 |
5.523700E-02 |
| Normal-vs-Stage4 |
1.202000E-01 |
| Stage1-vs-Stage2 |
2.436200E-01 |
| Stage1-vs-Stage3 |
6.572200E-02 |
| Stage1-vs-Stage4 |
1.302610E-01 |
| Stage2-vs-Stage3 |
7.263800E-01 |
| Stage2-vs-Stage4 |
3.361200E-01 |
| Stage3-vs-Stage4 |
4.330800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.123430E-01 |
| Normal-vs-AfricanAmerican |
2.589400E-01 |
| Normal-vs-Asian |
7.530400E-01 |
| Caucasian-vs-AfricanAmerican |
9.813200E-01 |
| Caucasian-vs-Asian |
5.438400E-01 |
| AfricanAmerican-vs-Asian |
5.657800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.365800E-01 |
| Normal-vs-Female |
1.259870E-03 |
| Male-vs-Female |
2.041000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.563200E-01 |
| Normal-vs-Extreme_Weight |
9.868200E-01 |
| Normal-vs-Obese |
1.924330E-02 |
| Normal-vs-Extreme_Obese |
2.166600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.151400E-01 |
| Normal_Weight-vs-Obese |
2.406000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.905900E-02 |
| Extreme_Weight-vs-Obese |
1.847660E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.936400E-01 |
| Obese-vs-Extreme_Obese |
5.943800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.985900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.212080E-02 |
| Normal-vs-Age(61-80Yrs) |
8.256400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.035800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.606630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.417500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.699780E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.369690E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.447500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.178000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.653400E-01 |
| Normal-VS-Type2 PRCC |
8.406000E-01 |
| Normal-VS-KIRP CIMP |
4.177900E-03 |
| Normal-VS-Unclassified PRCC |
4.260300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.243600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.895600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.685900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.000500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.442100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.123320E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.569000E-01 |
| Normal-vs-N1 |
1.415240E-03 |
| Normal-vs-N2 |
2.647400E-01 |
| N0-vs-N1 |
8.986500E-04 |
| N0-vs-N2 |
2.410000E-01 |
| N1-vs-N2 |
6.729800E-01 |
|
|
